In previous studies, chebulinic acid was shown to have an antagonistic effect on type 2 diabetes by inhibiting the protein tyrosine phosphatase non-receptor (PTPN)-11 and PTPN9 [36]. This evidence concerns the gene PTPN9 and type 2 diabetes mellitus.